Records 1 - 6
| The association of transporter ABCC2 (MRP2) genetic variation and drug-induced hyperbilirubinemia.
Journal of the Chinese Medical Association : JCMA 2020 Dec Publish Ahead of Print .
Huang Yi-Shin, Chang Tien-En, Perng Chin-Lin, Huang Yi-Hsia
| Association between genetic polymorphisms of SLCO1B1 and susceptibility to methimazole-induced liver injury.
Basic & clinical pharmacology & toxicology 2019 Jun .
Jin Shasha, Li Xuesong, Fan Yujuan, Fan Xiaofang, Dai Yu, Lin Haishu, Cai Weimin, Yang Jialin, Xiang Xiaoqia
| Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy.
BMC infectious diseases 2018 Nov 18 (1): 556.
Giacomelli Andrea, Riva Agostino, Falvella Felicia Stefania, Oreni Maria Letizia, Cattaneo Dario, Cheli Stefania, Renisi Giulia, Di Cristo Valentina, Lupo Angelica, Clementi Emilio, Rusconi Stefano, Galli Massimo, Ridolfo Anna Li
| Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort.
PloS one 2014 9 (4): e94675.
Ulzurrun Eugenia, Stephens Camilla, Ruiz-Cabello Francisco, Robles-Diaz Mercedes, Saenz-López Pablo, Hallal Hacibe, Soriano German, Roman Eva, Fernandez M Carmen, Lucena M Isabel, Andrade Raúl
| High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study.
The pharmacogenomics journal 2012 Dec 12 (6): 499-506.
Yimer G, Amogne W, Habtewold A, Makonnen E, Ueda N, Suda A, Worku A, Haefeli W E, Burhenne J, Aderaye G, Lindquist L, Aklillu
| Polymorphisms in drug transporter genes (ABCB1, SLCO1B1 and ABCC2) and hepatitis induced by antituberculosis drugs.
Tuberculosis (Edinburgh, Scotland) 2012 Jan 92 (1): 100-4.
Kim Sang-Hoon, Kim Sang-Heon, Lee Jae-Hyung, Lee Byoung-Hoon, Kim Youn-Seup, Park Jae-Seuk, Jee Young-K